Viva Biotech Holdings (VBIZF)
USD 0.11
(0.0%)
USD 0.11
(0.0%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 383.4 Million | 386.05 Million | 77.83 Million | 32.16 Million | 46.01 Million | 12.11 Million |
| Net Income | -55.95 Million | -459.16 Million | 347.7 Million | -356.21 Million | 280.92 Million | 105.86 Million |
| Depreciation & Amortization | 211.21 Million | 185.45 Million | 153.15 Million | 69.91 Million | 34.04 Million | 9.54 Million |
| Deferred income taxes | - | 510.56 Million | -255.7 Million | -153.67 Million | -249.57 Million | -90.39 Million |
| Stock-based compensation | 19 Million | 24.81 Million | 20.58 Million | 14.04 Million | 8.33 Million | 8.6 Million |
| Change in working capital | 31.41 Million | -17.9 Million | -261.51 Million | -73.73 Million | -3.75 Million | -20.54 Million |
| Other non-cash items | 344.2 Million | 142.29 Million | 73.61 Million | 531.81 Million | -23.95 Million | -961 Thousand |
| Investing Cash Flow | 439.17 Million | -372.8 Million | -868.83 Million | -3.83 Billion | -290.05 Million | -69.94 Million |
| Investments in PPE | -187.83 Million | -249.54 Million | -566.32 Million | -617.86 Million | -61.82 Million | -46.9 Million |
| Acquisitions | 3.84 Million | -81.2 Million | -210.87 Million | -2.5 Billion | -73.5 Million | 1.76 Million |
| Investment purchases | -64.45 Million | -233.23 Million | -2.1 Billion | -3.83 Billion | -1.79 Billion | -94.89 Million |
| Sales/Maturities of investments | 117.4 Million | 164.87 Million | 1.98 Billion | 3.73 Billion | 1.61 Billion | 66.58 Million |
| Other Investing Activities | 513.19 Million | 26.29 Million | 30.57 Million | -610.85 Million | 24.53 Million | 3.5 Million |
| Financing Cash Flow | -429.5 Million | -143.19 Million | -653.15 Million | 5.3 Billion | 984.86 Million | 179.47 Million |
| Debt repayment | -825.34 Million | -740.91 Million | -975.55 Million | -53.3 Million | -21.12 Million | -471 Thousand |
| Dividends payments | - | - | -16.27 Million | -51.79 Million | -135.83 Million | - |
| Common Stock Repurchased | -10.27 Million | - | -146.19 Million | -66.26 Million | -132.44 Million | - |
| Common Stock Issuance | - | - | 18.22 Million | 984.26 Million | 1.34 Billion | - |
| Other Financing Activities | 501 Million | 597.71 Million | 466.63 Million | 4.49 Billion | -71.37 Million | 179.95 Million |
| Accounts receivables | 30.43 Million | -22.3 Million | -98.51 Million | -41.52 Million | -7.85 Million | -29.1 Million |
| Accounts payables | - | - | - | - | - | - |
| Inventory | 57.04 Million | -96.44 Million | -69.07 Million | -1 Million | -3.63 Million | -1.57 Million |
| Other working capital | 44.02 Million | 78.53 Million | -192.44 Million | -72.72 Million | -126 Thousand | -18.96 Million |
| Cash at beginning of period | 678.56 Million | 800.94 Million | 2.3 Billion | 904.09 Million | 155.55 Million | 29.76 Million |
| Cash at end of period | 1.03 Billion | 678.56 Million | 800.94 Million | 2.3 Billion | 904.09 Million | 155.55 Million |
| Capital Expenditure | -187.83 Million | -249.54 Million | -566.32 Million | -617.86 Million | -61.82 Million | -46.9 Million |
| Effect of forex changes on cash | -35.32 Million | 7.57 Million | -63.34 Million | -96.9 Million | 7.71 Million | 4.14 Million |
| Net cash flow / Change in cash | 357.75 Million | -122.37 Million | -1.5 Billion | 1.4 Billion | 748.53 Million | 125.78 Million |
| Free Cash Flow | 195.56 Million | 136.5 Million | -488.49 Million | -585.69 Million | -15.81 Million | -34.79 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 8.03 Million | 8.08 Million | -55.95 Million | -16.2 Million | -8.02 Million | 146.15 Thousand |
| Depreciation & Amortization | 7.15 Million | 7.2 Million | 211.21 Million | 14.58 Million | 6.91 Million | 15.25 Million |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | -613.69 Thousand | -617.68 Thousand | 19 Million | 500.43 Thousand | 486.5 Thousand | 820.25 Thousand |
| Change in working capital | -2.13 Million | -2.14 Million | 31.41 Million | -14.28 Million | -2.64 Million | 18.55 Million |
| Other non-cash items | -1.96 Million | -1.97 Million | 344.2 Million | 64.71 Million | 7.78 Million | 23.64 Million |
| Investing Cash Flow | 13.86 Million | 13.95 Million | 439.17 Million | 140.03 Million | 36.33 Million | -14.15 Million |
| Investments in PPE | -8.83 Million | -8.88 Million | -187.83 Million | -10.33 Million | -5.89 Million | -13.77 Million |
| Acquisitions | 7.16 Million | - | 3.84 Million | 73.85 Million | - | 38.95 Thousand |
| Investment purchases | -1.84 Million | - | -64.45 Million | -26.89 Million | - | -3.14 Million |
| Sales/Maturities of investments | 38.49 Million | - | 117.4 Million | 100.91 Million | - | 5.21 Million |
| Other Investing Activities | 22.7 Million | 22.84 Million | 513.19 Million | 2.46 Million | 42.23 Million | -2.48 Million |
| Financing Cash Flow | -24.39 Million | -24.55 Million | -429.5 Million | -144.35 Million | -39.04 Million | 25.29 Million |
| Debt repayment | -49.98 Million | - | -825.34 Million | -80.06 Million | - | -884.84 Thousand |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | -10.27 Million | 5.31 Million | -703.6 Thousand | -6.71 Million |
| Common Stock Issuance | - | - | - | 26.85 Million | - | 31.37 Million |
| Other Financing Activities | -24.39 Million | -24.55 Million | 501 Million | -256.22 Million | -38.34 Million | -39.96 Thousand |
| Accounts receivables | -3.02 Million | -3.04 Million | 30.43 Million | -10.28 Million | -3.63 Million | 14.11 Million |
| Accounts payables | 239.18 Thousand | - | - | -4.63 Million | - | -6.45 Million |
| Inventory | 2.27 Million | 2.28 Million | 57.04 Million | 863.57 Thousand | 583.27 Thousand | 7 Million |
| Other working capital | -1.37 Million | -1.38 Million | 44.02 Million | -4.88 Million | 400.83 Thousand | 3.89 Million |
| Cash at beginning of period | 146.08 Million | - | 678.56 Million | 202.26 Million | - | 99.03 Million |
| Cash at end of period | 148.57 Million | -5610.00 | 1.03 Billion | 146.08 Million | -2.55 Million | 202.26 Million |
| Capital Expenditure | -8.83 Million | -8.88 Million | -187.83 Million | -10.33 Million | -5.89 Million | -13.77 Million |
| Effect of forex changes on cash | 42.03 Thousand | 42.31 Thousand | -35.32 Million | -4.48 Million | -4.36 Million | 1.95 Million |
| Net cash flow / Change in cash | 2.49 Million | -5610.00 | 357.75 Million | -56.18 Million | -2.55 Million | 103.23 Million |
| Free Cash Flow | 1.64 Million | 1.66 Million | 195.56 Million | -4.73 Million | -1.37 Million | 27.98 Million |
1183
1867
3024
NFN
PLBY
3018